# CRISPR Gene Therapy Shows 97% Success Rate in Long-Term Sickle Cell Trial

- slug: crispr-gene-therapy-shows-97-success-rate-in-long-term-sickle-cell-trial
- date: 2026-03-12

A CRISPR-based gene therapy continues showing remarkable results for patients with sickle cell disease, according to data published in the New England Journal of Medicine.

Casgevy (exagamglogene autotemcel), the first FDA-approved therapy developed using CRISPR gene-editing technology, achieved ...

---